Trademarkia Logo

Canada

C$
Trademark Search in Canada
TRINTELLIX vortioxetine tablets & Design
TRINTELLIX vortioxetine tablets & Design
REGISTERED

on 9 Dec 2019

Last Applicant/ Owned by

H. Lundbeck A/S

Ottiliavej 9, 2500 Valby

DK

Serial Number

1815669 filed on 22nd Dec 2016

Registration Number

TMA1065701 registered on 9th Dec 2019

Registration expiry Date

9th Dec 2029

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

TRINTELLIX vortioxetine tablets & Design

Trademark usage description

pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or ac Read More

Vienna Information


26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 22

Set of lines evoking sound or electromagnetic wavesEnsemble de lignes évoquant les ondes sonores ou électromagnétiques

26 . 1 . 1

CirclesCercles

26 . 1 . 5

More than two circles or ellipses, inside one another, spiralsPlus de deux cercles ou ellipses, les uns dans les autres, spirales

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information


Class [005]
Pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; diagnostic reagents and agents for medical diagnostic use


Classification kind code

10

Mark Details


Serial Number

1815669

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 12th Aug 2019
Approved
Submitted for opposition 27
on 12th Aug 2019
Approval Notice Sent
Submitted for opposition 15
on 15th May 2019
Correspondence Created
Submitted for opposition 15
on 25th Sept 2018
Correspondence Created
Submitted for opposition 12
on 30th Jan 2018
Extension of Time
Submitted for opposition 22
on 21st Jul 2017
Search Recorded
Submitted for opposition 20
on 21st Jul 2017
Examiner's First Report
Submitted for opposition 31
on 29th Dec 2016
Formalized
Submitted for opposition 1
on 28th Dec 2016
Created
Submitted for opposition 30
on 22nd Dec 2016
Filed